CSIMarket
 
Inventiva S a   (IVA)
 

The Major Pharmaceutical Preparations company released Revenue of $13.64048 millions, in the fourth quarter of 2022

Inventiva S A delivered fourth quarter of 2022 operating shortfall of $-63.9632 millions


Published Apr 02 2023
CSIMarket Team / CSIMarket.com


pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons IVA proclaimed $13.64048 millions, in Revenue in the fourth quarter of 2022.




For the fourth quarter of 2022 Inventiva S A realized net loss of $-60.787 million, higher than $-55.591 million a year ago.


Inventiva S A is expected to report next financial recent numbers on March 29, 2024.



Inventiva S A's Dividend Comparisons

Inventiva S A's ROA



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com